Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
The report details the trend, potential and market size of Certolizumab pegol market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Certolizumab pegolmarket, defines the market attractiveness level of Certolizumab pegol market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Certolizumab pegol industry, describes the types of Certolizumab pegol market, the applications of major players and the market size, and deeply analyzes the current situation of the global Certolizumab pegol market and the development prospects and opportunities of Certolizumab pegol industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Certolizumab pegol market in Chapter 13.
By Player:
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
By Type:
Single-dose vial
Single-dose prefilled syringe
By End-User:
Crohn’s disease
Active rheumatoid arthritis
Active psoriatic arthritis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Certolizumab pegol Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Certolizumab pegol Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Certolizumab pegol Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Certolizumab pegol Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Certolizumab pegol Market Analysis and Outlook to 2022
-
7.1 Global Certolizumab pegol Consumption (2017-2022)
-
7.2 United States Certolizumab pegol Consumption (2017-2022)
-
7.3 Europe Certolizumab pegol Consumption (2017-2022)
-
7.4 China Certolizumab pegol Consumption (2017-2022)
-
7.5 Japan Certolizumab pegol Consumption (2017-2022)
-
7.6 India Certolizumab pegol Consumption (2017-2022)
-
7.7 South Korea Certolizumab pegol Consumption (2017-2022)
8 Region and Country-wise Certolizumab pegol Market Analysis and Outlook to 2028
-
8.1 Global Certolizumab pegol Consumption Forecast (2022-2028)
-
8.2 United States Certolizumab pegol Consumption Forecast (2022-2028)
-
8.3 Europe Certolizumab pegol Consumption Forecast (2022-2028)
-
8.4 China Certolizumab pegol Consumption Forecast (2022-2028)
-
8.5 Japan Certolizumab pegol Consumption Forecast (2022-2028)
-
8.6 India Certolizumab pegol Consumption Forecast (2022-2028)
-
8.7 South Korea Certolizumab pegol Consumption Forecast (2022-2028)
9 Global Certolizumab pegol Market Outlook by Types and Applications to 2022
-
9.1 Global Certolizumab pegol Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Single-dose vial Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Single-dose prefilled syringe Consumption and Growth Rate (2017-2022)
-
9.2 Global Certolizumab pegol Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Crohn’s disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Active rheumatoid arthritis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Active psoriatic arthritis Consumption and Growth Rate (2017-2022)
10 Global Certolizumab pegol Market Outlook by Types and Applications to 2028
-
10.1 Global Certolizumab pegol Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Single-dose vial Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Single-dose prefilled syringe Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Certolizumab pegol Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Crohn’s disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Active rheumatoid arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Active psoriatic arthritis Consumption Forecast and Growth Rate (2022-2028)
11 Global Certolizumab pegol Import and Export Analysis (Top 5 Countries)
-
11.1 Global Certolizumab pegol Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Certolizumab pegol Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Certolizumab pegol Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Certolizumab pegol Market Competitive Analysis
-
14.1 Company 1
-
14.1.1 Company 1 Company Details
-
14.1.2 Company 1 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Company 1 Certolizumab pegol Product and Service
-
14.2 Company 2
-
14.2.1 Company 2 Company Details
-
14.2.2 Company 2 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Company 2 Certolizumab pegol Product and Service
-
14.3 Company 3
-
14.3.1 Company 3 Company Details
-
14.3.2 Company 3 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Company 3 Certolizumab pegol Product and Service
-
14.4 Company 4
-
14.4.1 Company 4 Company Details
-
14.4.2 Company 4 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Company 4 Certolizumab pegol Product and Service
-
14.5 Company 5
-
14.5.1 Company 5 Company Details
-
14.5.2 Company 5 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Company 5 Certolizumab pegol Product and Service
-
14.6 Company 6
-
14.6.1 Company 6 Company Details
-
14.6.2 Company 6 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Company 6 Certolizumab pegol Product and Service
-
14.7 Company 7
-
14.7.1 Company 7 Company Details
-
14.7.2 Company 7 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Company 7 Certolizumab pegol Product and Service
-
14.8 Company 8
-
14.8.1 Company 8 Company Details
-
14.8.2 Company 8 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Company 8 Certolizumab pegol Product and Service
-
14.9 Company 9
-
14.9.1 Company 9 Company Details
-
14.9.2 Company 9 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Company 9 Certolizumab pegol Product and Service
-
14.10 Company 10
-
14.10.1 Company 10 Company Details
-
14.10.2 Company 10 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Company 10 Certolizumab pegol Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Certolizumab pegol
-
Figure Certolizumab pegol Picture
-
Table Global Certolizumab pegol Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Certolizumab pegol Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Certolizumab pegol Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Certolizumab pegol Consumption by Country (2017-2022)
-
Figure United States Certolizumab pegol Consumption and Growth Rate (2017-2022)
-
Table Europe Certolizumab pegol Consumption and Growth Rate (2017-2022)
-
Figure China Certolizumab pegol Consumption and Growth Rate (2017-2022)
-
Figure Japan Certolizumab pegol Consumption and Growth Rate (2017-2022)
-
Figure India Certolizumab pegol Consumption and Growth Rate (2017-2022)
-
Figure South Korea Certolizumab pegol Consumption and Growth Rate (2017-2022)
-
Figure Global Certolizumab pegol Consumption Forecast by Country (2022-2028)
-
Figure United States Certolizumab pegol Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Certolizumab pegol Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Certolizumab pegol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Certolizumab pegol Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Certolizumab pegol Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Certolizumab pegol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Single-dose vial Consumption and Growth Rate (2017-2022)
-
Figure Global Single-dose prefilled syringe Consumption and Growth Rate (2017-2022)
-
Figure Global Crohn’s disease Consumption and Growth Rate (2017-2022)
-
Figure Global Active rheumatoid arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Active psoriatic arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Single-dose vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Single-dose prefilled syringe Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Crohn’s disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Active rheumatoid arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Active psoriatic arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Certolizumab pegol Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Certolizumab pegol Export by Region (Top 5 Countries) (2017-2028)
-
Table Company 1 (Foundation Year, Company Profile and etc.)
-
Table Company 1 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 1 Certolizumab pegol Product and Service
-
Table Company 2 (Foundation Year, Company Profile and etc.)
-
Table Company 2 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 2 Certolizumab pegol Product and Service
-
Table Company 3 (Foundation Year, Company Profile and etc.)
-
Table Company 3 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 3 Certolizumab pegol Product and Service
-
Table Company 4 (Foundation Year, Company Profile and etc.)
-
Table Company 4 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 4 Certolizumab pegol Product and Service
-
Table Company 5 (Foundation Year, Company Profile and etc.)
-
Table Company 5 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 5 Certolizumab pegol Product and Service
-
Table Company 6 (Foundation Year, Company Profile and etc.)
-
Table Company 6 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 6 Certolizumab pegol Product and Service
-
Table Company 7 (Foundation Year, Company Profile and etc.)
-
Table Company 7 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 7 Certolizumab pegol Product and Service
-
Table Company 8 (Foundation Year, Company Profile and etc.)
-
Table Company 8 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 8 Certolizumab pegol Product and Service
-
Table Company 9 (Foundation Year, Company Profile and etc.)
-
Table Company 9 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 9 Certolizumab pegol Product and Service
-
Table Company 10 (Foundation Year, Company Profile and etc.)
-
Table Company 10 Certolizumab pegol Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 10 Certolizumab pegol Product and Service
-
